Antipsychotic drugs double risk of death among Alzheimer's patients
Friday, January 9, 2009 - 04:21
in Health & Medicine
New research into the effects of antipsychotic drugs commonly prescribed to Alzheimer's patients concludes that the medication nearly doubles risk of death over three years. The study, funded by the Alzheimer's Research Trust, was led by Prof Clive Ballard's King's College London team and is published in Lancet Neurology on 9 January.